Haemonetics Stock Dips After Citigroup Downgrade
Update: 2025-12-11
Description
Citigroup downgrades Haemonetics to Neutral, shares drop by 2%: Despite raising price target, investors react negatively to changed outlook.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
